Cost-benefit analysis of a program for vaccination against hepatitis B in health personnel of a hospital
Rivera, F.; Lissen, E.; Vázquez, R.; Arroyo, F.; Sánchez-Quijano, A.; García de Pesquera, F.; Leal, M.; Lozano, F.; Cordero, A.; Herrera, C.
Medicina Clinica 83(15): 611-614
1984
ISSN/ISBN: 0025-7753 PMID: 6441088 Document Number: 235394
Document emailed within 1 workday
Related Documents
Jönsson, B. 1987: Cost-benefit analysis of hepatitis B vaccination Postgraduate Medical Journal 63(Suppl 2): 27-32Gutersohn, T.; Steffen, R.; Van Damme, P.; Holdener, F.; Beutels, P. 1996: Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination Aviation Space and Environmental Medicine 67(2): 153-156
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Stelling, T.; van Hattum, J.; de Gast, G.C. 1984: Hepatitis B vaccination of hospital personnel Nederlands Tijdschrift Voor Geneeskunde 128(37): 1753-1757
Mori, A.Thomas.; Kampata, L.; Musonda, P.; Johansson, K.Arne.; Robberstad, B.; Sandøy, I. 2017: Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial Trials 18(1): 604
Abbas, M.; Fiala, L.; Tawfiq, L. 2006: Workplace influenza vaccination in two major industries in saudi arabia: a cost benefit analysis Journal of the Egyptian Public Health Association 81(1-2): 59-73
Duff, P.; Dolphin, C. 2007: Cost-benefit analysis of assistive technology to support independence for people with dementia – Part 2: Results from employing the ENABLE cost-benefit model in practice Technology and Disability 19(2-3): 79-90
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158
Rodriguez, M.Isabel.; Caughey, A.B.; Edelman, A.; Darney, P.D.; Foster, D.Greene. 2010: Cost-benefit analysis of state- and hospital-funded postpartum intrauterine contraception at a university hospital for recent immigrants to the United States Contraception 81(4): 304-308
Lopez Boo, F.; Palloni, G.; Urzua, S. 2014: Cost-benefit analysis of a micronutrient supplementation and early childhood stimulation program in Nicaragua Annals of the new York Academy of Sciences 1308: 139-148
La Croix, S.J.; Russo, G. 1996: A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients Social Science and Medicine (1982) 42(9): 1259-1272
Swenson, L.; Audell, L.; Hedhammar, A. 1997: Prevalence and inheritance of and selection for hip dysplasia in seven breeds of dogs in Sweden and benefit: cost analysis of a screening and control program Journal of the American Veterinary Medical Association 210(2): 207-214
Rokossowski, H.; Juszczyk, J. 1992: The comparison of dynamics in humoral responses in health personnel after vaccination against hepatitis B using Engerix B and Gen-H-B-vax Przeglad Epidemiologiczny 46(4): 263-269
Swenson, L.; Audell, L.; Hedhammar, A. 1997: Prevalence and inheritance of and selection for elbow arthrosis in Bernese mountain dogs and Rottweilers in Sweden and benefit: cost analysis of a screening and control program Journal of the American Veterinary Medical Association 210(2): 215-221
Hutton, J. 1992: Cost-benefit analysis in health care expenditure decision-making Health Economics 1(4): 213-216
Riaño-Casallas, M.I.; Tompa, E. 2018: Cost-benefit analysis of investment in occupational health and safety in Colombian companies American Journal of Industrial Medicine 61(11): 893-900
Maestre Sánchez, A. 1985: Viral hepatitis as an occupational disease in hospital health personnel. Health and economic importance Revista de Sanidad E Higiene Publica 59(7-8): 907-923
Su, S-Yung. 2019: The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan Hepatology International 13(2): 157-164
Zhong, Y.; Wu, X. 2020: Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects Plos one 15(3): E0229739
Novaes, H.Maria.Dutilh.; de Soárez, Pícia.Coelho.; Silva, G.Azevedo.; Ayres, A.; Itria, A.; Rama, C.Helena.; Sartori, A.Marli.Christovam.; Clark, A.D.; Resch, S. 2015: Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil Vaccine 33 Suppl. 1: A135-A142